As of 4:00pm ET
| -0.98 / -3.59%|
The 8 analysts offering 12-month price forecasts for Medicines Co have a median target of 51.50, with a high estimate of 85.00 and a low estimate of 38.00. The median estimate represents a +95.67% increase from the last price of 26.32.
The current consensus among 7 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.